Results
Jubilant Pharmova Approves FY26 Results, 500% Dividend
Board approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026.
Recommended a final dividend of ₹5 per equity share (500%) for FY26, with July 24, 2
